Company Profile

Vault Nano Inc (AKA: Vault Pharma)
Profile last edited on: 1/23/2018      CAGE: 7KXU2      UEI: FGNQRR6TJQU9

Business Identifier: Immune medicines addressing treatment outcomes in solid tumors and women’s health
Year Founded
2015
First Award
2016
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9301 Wilshire Boulevard Suite 507
Beverly Hills, CA 90210
   (310) 428-5793
   N/A
   www.vaultpharma.com
Location: Single
Congr. District: 33
County: Los Angeles

Public Profile

Vault Nano Inc. is biotechnology company developing and commercializing immune therapy for cancer and infectious diseases. Located in CNSI Incubator (California NanoSystems Institute) at UCLA , Vault Pharma's ImmunOncologyTM portfolio is a group of new medicines activating specific responses of the immune system to destroy cancer. Vault Nano’s lead cancer drug, VNI-101, is a cytokine-based immune stimulant delivered by a novel human protein nanoparticle. Discovered by the Rome Laboratory at UCLA, the ImmunOncologyTM portfolio is based on a novel human protein nanoparticle, called a vault. VNI’s therapies are designed to have clinical impact in multiple metastatic cancers.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Oliver Foellmer -- President and Chief Executive Officer.

  Valerie Kickhoefer

Company News

There are no news available.